دورية أكاديمية
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
العنوان: | Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) |
---|---|
المؤلفون: | Fasching, P.A., Link, T., Hauke, J., Seither, F., Jackisch, C., Klare, P., Schmatloch, S., Hanusch, C., Huober, J., Stefek, A., Seiler, S., Schmitt, W.D., Uleer, C., Doering, G., Rhiem, K., Schneeweiss, A., Engels, K., Denkert, C., Schmutzler, R.K., Hahnen, E., Untch, M., Burchardi, N., Blohmer, J.-U., Loibl, S. |
المساهمون: | Myriad Genetics |
المصدر: | Annals of Oncology ; volume 32, issue 1, page 49-57 ; ISSN 0923-7534 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2021 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.annonc.2020.10.471 |
الإتاحة: | https://doi.org/10.1016/j.annonc.2020.10.471Test https://api.elsevier.com/content/article/PII:S0923753420429631?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753420429631?httpAccept=text/plainTest |
حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
رقم الانضمام: | edsbas.49A0B8DB |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.annonc.2020.10.471 |
---|